GO:0071339 | MLL1 complex | 3.18e-09 | 4.59e-05 | 7.602 | 4 | 6 | 27 |
GO:0043995 | histone acetyltransferase activity (H4-K5 specific) | 2.77e-08 | 3.99e-04 | 8.772 | 3 | 5 | 9 |
GO:0046972 | histone acetyltransferase activity (H4-K16 specific) | 2.77e-08 | 3.99e-04 | 8.772 | 3 | 5 | 9 |
GO:0048188 | Set1C/COMPASS complex | 2.77e-08 | 3.99e-04 | 8.772 | 3 | 4 | 9 |
GO:0043996 | histone acetyltransferase activity (H4-K8 specific) | 2.77e-08 | 3.99e-04 | 8.772 | 3 | 5 | 9 |
GO:0005654 | nucleoplasm | 1.32e-07 | 1.90e-03 | 3.277 | 8 | 64 | 1082 |
GO:0043981 | histone H4-K5 acetylation | 1.49e-07 | 2.16e-03 | 8.035 | 3 | 5 | 15 |
GO:0043982 | histone H4-K8 acetylation | 1.49e-07 | 2.16e-03 | 8.035 | 3 | 5 | 15 |
GO:0043984 | histone H4-K16 acetylation | 3.18e-07 | 4.58e-03 | 7.694 | 3 | 5 | 19 |
GO:0000123 | histone acetyltransferase complex | 4.36e-07 | 6.28e-03 | 7.549 | 3 | 6 | 21 |
GO:0006355 | regulation of transcription, DNA-templated | 3.67e-05 | 5.30e-01 | 2.980 | 6 | 43 | 997 |
GO:0042800 | histone methyltransferase activity (H3-K4 specific) | 4.11e-05 | 5.92e-01 | 7.656 | 2 | 3 | 13 |
GO:0031011 | Ino80 complex | 4.79e-05 | 6.91e-01 | 7.549 | 2 | 6 | 14 |
GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex | 5.52e-05 | 7.97e-01 | 7.450 | 2 | 3 | 15 |
GO:0051568 | histone H3-K4 methylation | 7.15e-05 | 1.00e+00 | 7.269 | 2 | 3 | 17 |
GO:0006325 | chromatin organization | 8.40e-05 | 1.00e+00 | 5.059 | 3 | 12 | 118 |
GO:0035097 | histone methyltransferase complex | 1.10e-04 | 1.00e+00 | 6.964 | 2 | 3 | 21 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.97e-04 | 1.00e+00 | 3.646 | 4 | 30 | 419 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 7.63e-04 | 1.00e+00 | 10.357 | 1 | 1 | 1 |
GO:0006310 | DNA recombination | 1.07e-03 | 1.00e+00 | 5.334 | 2 | 7 | 65 |
GO:0005515 | protein binding | 1.10e-03 | 1.00e+00 | 1.122 | 10 | 198 | 6024 |
GO:0010467 | gene expression | 1.17e-03 | 1.00e+00 | 2.971 | 4 | 45 | 669 |
GO:0060242 | contact inhibition | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0019046 | release from viral latency | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 2 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.52e-03 | 1.00e+00 | 9.357 | 1 | 1 | 2 |
GO:0003682 | chromatin binding | 1.66e-03 | 1.00e+00 | 3.588 | 3 | 19 | 327 |
GO:0060913 | cardiac cell fate determination | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.29e-03 | 1.00e+00 | 8.772 | 1 | 1 | 3 |
GO:0070461 | SAGA-type complex | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0001714 | endodermal cell fate specification | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 3.81e-03 | 1.00e+00 | 8.035 | 1 | 2 | 5 |
GO:0016589 | NURF complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.57e-03 | 1.00e+00 | 7.772 | 1 | 3 | 6 |
GO:0072357 | PTW/PP1 phosphatase complex | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 2 | 7 |
GO:0070688 | MLL5-L complex | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0043254 | regulation of protein complex assembly | 6.09e-03 | 1.00e+00 | 7.357 | 1 | 1 | 8 |
GO:0000398 | mRNA splicing, via spliceosome | 6.61e-03 | 1.00e+00 | 3.999 | 2 | 15 | 164 |
GO:0044212 | transcription regulatory region DNA binding | 6.92e-03 | 1.00e+00 | 3.964 | 2 | 17 | 168 |
GO:0035413 | positive regulation of catenin import into nucleus | 7.60e-03 | 1.00e+00 | 7.035 | 1 | 2 | 10 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 8.36e-03 | 1.00e+00 | 6.897 | 1 | 4 | 11 |
GO:0005838 | proteasome regulatory particle | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 9.12e-03 | 1.00e+00 | 6.772 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0045722 | positive regulation of gluconeogenesis | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 13 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0030234 | enzyme regulator activity | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 2 | 13 |
GO:0003677 | DNA binding | 1.03e-02 | 1.00e+00 | 2.106 | 4 | 49 | 1218 |
GO:0001824 | blastocyst development | 1.14e-02 | 1.00e+00 | 6.450 | 1 | 2 | 15 |
GO:0043274 | phospholipase binding | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 1.21e-02 | 1.00e+00 | 6.357 | 1 | 2 | 16 |
GO:0008380 | RNA splicing | 1.25e-02 | 1.00e+00 | 3.524 | 2 | 22 | 228 |
GO:0022624 | proteasome accessory complex | 1.29e-02 | 1.00e+00 | 6.269 | 1 | 1 | 17 |
GO:0003713 | transcription coactivator activity | 1.34e-02 | 1.00e+00 | 3.468 | 2 | 24 | 237 |
GO:0006281 | DNA repair | 1.61e-02 | 1.00e+00 | 3.329 | 2 | 14 | 261 |
GO:0045787 | positive regulation of cell cycle | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 2 | 22 |
GO:0001205 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.67e-02 | 1.00e+00 | 5.897 | 1 | 4 | 22 |
GO:0035329 | hippo signaling | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 5 | 26 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.41e-02 | 1.00e+00 | 5.357 | 1 | 2 | 32 |
GO:0003723 | RNA binding | 2.68e-02 | 1.00e+00 | 2.939 | 2 | 18 | 342 |
GO:0005634 | nucleus | 2.89e-02 | 1.00e+00 | 1.010 | 7 | 159 | 4559 |
GO:0035019 | somatic stem cell maintenance | 3.01e-02 | 1.00e+00 | 5.035 | 1 | 6 | 40 |
GO:0031124 | mRNA 3'-end processing | 3.16e-02 | 1.00e+00 | 4.964 | 1 | 2 | 42 |
GO:0043966 | histone H3 acetylation | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 5 | 45 |
GO:0006369 | termination of RNA polymerase II transcription | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 2 | 45 |
GO:0006521 | regulation of cellular amino acid metabolic process | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 1 | 50 |
GO:0009611 | response to wounding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 5 | 52 |
GO:0044822 | poly(A) RNA binding | 4.14e-02 | 1.00e+00 | 1.897 | 3 | 50 | 1056 |
GO:0000502 | proteasome complex | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 58 |
GO:0006396 | RNA processing | 4.41e-02 | 1.00e+00 | 4.474 | 1 | 5 | 59 |
GO:0006406 | mRNA export from nucleus | 4.56e-02 | 1.00e+00 | 4.426 | 1 | 4 | 61 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 4.78e-02 | 1.00e+00 | 4.357 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 2 | 65 |
GO:0010468 | regulation of gene expression | 5.07e-02 | 1.00e+00 | 4.269 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.21e-02 | 1.00e+00 | 4.227 | 1 | 2 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 5.36e-02 | 1.00e+00 | 4.187 | 1 | 1 | 72 |
GO:0000785 | chromatin | 5.43e-02 | 1.00e+00 | 4.167 | 1 | 6 | 73 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 2 | 74 |
GO:0002020 | protease binding | 5.50e-02 | 1.00e+00 | 4.147 | 1 | 6 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 5.58e-02 | 1.00e+00 | 4.128 | 1 | 1 | 75 |
GO:0071013 | catalytic step 2 spliceosome | 5.79e-02 | 1.00e+00 | 4.071 | 1 | 7 | 78 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.86e-02 | 1.00e+00 | 4.053 | 1 | 2 | 79 |
GO:0009653 | anatomical structure morphogenesis | 6.15e-02 | 1.00e+00 | 3.982 | 1 | 2 | 83 |
GO:0006464 | cellular protein modification process | 6.23e-02 | 1.00e+00 | 3.964 | 1 | 4 | 84 |
GO:0050821 | protein stabilization | 6.51e-02 | 1.00e+00 | 3.897 | 1 | 3 | 88 |
GO:0001649 | osteoblast differentiation | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 5 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 6.80e-02 | 1.00e+00 | 3.833 | 1 | 1 | 92 |
GO:0016568 | chromatin modification | 7.23e-02 | 1.00e+00 | 3.742 | 1 | 4 | 98 |
GO:0030529 | ribonucleoprotein complex | 8.22e-02 | 1.00e+00 | 3.549 | 1 | 5 | 112 |
GO:0000209 | protein polyubiquitination | 8.50e-02 | 1.00e+00 | 3.499 | 1 | 3 | 116 |
GO:0001501 | skeletal system development | 8.71e-02 | 1.00e+00 | 3.462 | 1 | 2 | 119 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 9.66e-02 | 1.00e+00 | 1.908 | 2 | 39 | 699 |
GO:0010628 | positive regulation of gene expression | 1.06e-01 | 1.00e+00 | 3.167 | 1 | 7 | 146 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 3 | 149 |
GO:0006974 | cellular response to DNA damage stimulus | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 7 | 151 |
GO:0042981 | regulation of apoptotic process | 1.09e-01 | 1.00e+00 | 3.128 | 1 | 4 | 150 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 1.19e-01 | 1.00e+00 | 1.733 | 2 | 41 | 789 |
GO:0005730 | nucleolus | 1.21e-01 | 1.00e+00 | 1.261 | 3 | 66 | 1641 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.23e-01 | 1.00e+00 | 2.939 | 1 | 2 | 171 |
GO:0016607 | nuclear speck | 1.24e-01 | 1.00e+00 | 2.930 | 1 | 12 | 172 |
GO:0007049 | cell cycle | 1.25e-01 | 1.00e+00 | 2.914 | 1 | 6 | 174 |
GO:0005667 | transcription factor complex | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 17 | 175 |
GO:0031625 | ubiquitin protein ligase binding | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 5 | 178 |
GO:0003714 | transcription corepressor activity | 1.28e-01 | 1.00e+00 | 2.881 | 1 | 11 | 178 |
GO:0016020 | membrane | 1.28e-01 | 1.00e+00 | 1.227 | 3 | 46 | 1681 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.32e-01 | 1.00e+00 | 2.833 | 1 | 22 | 184 |
GO:0005737 | cytoplasm | 1.33e-01 | 1.00e+00 | 0.799 | 5 | 124 | 3767 |
GO:0016071 | mRNA metabolic process | 1.58e-01 | 1.00e+00 | 2.556 | 1 | 8 | 223 |
GO:0008134 | transcription factor binding | 1.70e-01 | 1.00e+00 | 2.438 | 1 | 18 | 242 |
GO:0043025 | neuronal cell body | 1.72e-01 | 1.00e+00 | 2.420 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 8 | 247 |
GO:0000166 | nucleotide binding | 1.81e-01 | 1.00e+00 | 2.340 | 1 | 13 | 259 |
GO:0006954 | inflammatory response | 1.92e-01 | 1.00e+00 | 2.243 | 1 | 6 | 277 |
GO:0008283 | cell proliferation | 2.24e-01 | 1.00e+00 | 1.999 | 1 | 14 | 328 |
GO:0043565 | sequence-specific DNA binding | 2.34e-01 | 1.00e+00 | 1.922 | 1 | 11 | 346 |
GO:0000278 | mitotic cell cycle | 2.61e-01 | 1.00e+00 | 1.746 | 1 | 15 | 391 |
GO:0009986 | cell surface | 2.67e-01 | 1.00e+00 | 1.706 | 1 | 9 | 402 |
GO:0043066 | negative regulation of apoptotic process | 2.80e-01 | 1.00e+00 | 1.629 | 1 | 16 | 424 |
GO:0005829 | cytosol | 2.94e-01 | 1.00e+00 | 0.656 | 3 | 86 | 2496 |
GO:0006351 | transcription, DNA-templated | 3.04e-01 | 1.00e+00 | 0.859 | 2 | 57 | 1446 |
GO:0042802 | identical protein binding | 3.13e-01 | 1.00e+00 | 1.438 | 1 | 19 | 484 |
GO:0016032 | viral process | 3.40e-01 | 1.00e+00 | 1.296 | 1 | 26 | 534 |
GO:0006915 | apoptotic process | 3.51e-01 | 1.00e+00 | 1.240 | 1 | 12 | 555 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.58e-01 | 1.00e+00 | 1.202 | 1 | 37 | 570 |
GO:0005739 | mitochondrion | 5.46e-01 | 1.00e+00 | 0.394 | 1 | 23 | 998 |
GO:0044281 | small molecule metabolic process | 6.19e-01 | 1.00e+00 | 0.115 | 1 | 20 | 1211 |
GO:0005524 | ATP binding | 6.46e-01 | 1.00e+00 | 0.015 | 1 | 31 | 1298 |
GO:0070062 | extracellular vesicular exosome | 8.65e-01 | 1.00e+00 | -0.872 | 1 | 57 | 2400 |